Back to Awarded Treatment Trials
Awarded Trial: 07TGF-1163
Grant ID
07TGF-1163
Illness
Bipolar depression
Primary Drug/Intervention
Zonisamide
Primary Dosage
100-300 mg/day
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Rosenthal
Sample Size
100
Duration of Study Period for Each Subject
12 weeks
Outcome Measurements
CGI, YMRS, QIDS, Q-LES-Q, MADRS
Results
One hundred and two (102) patients with BP I or II in a depressed phase were randomized to zonisamide 300 mg for 6 weeks. There was a large placebo response, but the groups did not differ significantly in outcome measures.
Publication
N/A
Link
N/A
PI Name
Norman Rosenthal
Degree
MD
Center
N/A
Institution
Capital Clinical Research Associates
Address
5515 Security Lane, Suite 525
City or Town
Rockville
State or Province
MD
Zip or Postal Code
20852
Country
USA
Email Address
norm.rosenthal@gmail.com